Announcements Align Summit 2026 returns in October to connect funders with breakthrough startups Jun 16, 2026
Member Viewpoints A Biomarker Approach to Elucidate Immune Reset: Lessons for T Cell Engagers in Autoimmune Diseases Jun 09, 2026
News J Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment Jun 17, 2026 Posted by Uniphar
.jpg)